Clinical Trial Update: Spontaneous Atrio Ventricular Conduction Preservation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by LivaNova focusing on spontaneous atrioventricular conduction preservation in patients with sinus node dysfunction, bradyca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia-tachycardia Syndrome
• Paroxysmal Atrioventricular Block
• Sinus Node Dysfunction

Snippet

Sponsor: LivaNova | Conditions: Sinus Node Dysfunction, Bradycardia-Tachycardia Syndrome | Phase 4 | Status: COMPLETED